Marvell Technology (MRVL): Restructuring Taking Hold - Needham

Needham & Company analyst, Quinn Bolton, reiterated his Hold rating on Marvell (NASDAQ: MRVL) following the results of a months-long strategic review of the business by new CEO, Matt Murphy.

Marvell will focus on its strengths in storing, moving and accessing data at high speeds and pursue two initiatives:
1) discontinue specific R&D programs, streamline engineering processes, and consolidate R&D sites to drive increased efficiency, which will result in a reduction of 900 positions worldwide; together with an anticipated meaningful reduction in legal and accounting costs, these actions are expected to reduce annualized NG OPEX by $180-200MM
2) divest certain non-strategic businesses that generated annualized revenue of ~$100MM and NG OPEX of ~$60MM in F1H17.

The restructuring actions in aggregate are expected to reduce annualized NG OPEX to a run rate of $820-840MM by the end of F3Q18 (Oct) from a current annualized run rate of $1,080MM. As a result of these actions, Marvell expects to incur related one-time charges of $90-110MM over the next four quarters, including cash charges of $35-50MM.

For an analyst ratings summary and ratings history on Marvell click here. For more ratings news on Marvell click here.

Shares of Marvell closed at $12.94 yesterday.

You May Also Be Interested In

• OncoCyte Corp (OCX) PT Raised to $4.25 at Needham
• EQT Corp. (EQT) PT Lowered to $46 at Wolfe Research
• Summit Insights Downgrades Silicon Labs (SLAB) to Hold, 'expect its stock to be an inline performer'